血液濃縮器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の血液濃縮器の市場規模は、2023年に1,163万米ドル、2030年までに1,404万米ドルに達し、2024年～2030年の予測期間にCAGRで3.24%の成長が見込まれます。市場は、心血管障害の負担の増加、老年人口の増加、各国の政府による取り組みの増加、血液濃縮器の安全性、入手性、使いやすさの向上への注目の高まりなどの要因によって成長が見込まれており、予測期間（2024年～2030年）に血液濃縮器市場の収益が大きく伸びる見込みです。

血液濃縮器の市場力学

血液濃縮器市場の注目すべき促進要因の1つは、心血管疾患の有病率の上昇です。

世界保健機関（WHO）（2022）のデータによると、心血管疾患は毎年約1,790万人の命に影響を与える世界最大の死因と考えられています。バイパス手術を必要とする心血管疾患には、主に冠動脈疾患、大動脈弁狭窄症、浮腫などの疾患が含まれます。

World Heart Federation（2019）による別の調査では、2030年までに心血管疾患により世界で2,300万人以上の命が影響を受けると推定されています。

心血管疾患の罹患率の増加は、不健康なライフスタイル、タバコの使用、高血圧、糖尿病、飲酒、肥満などの心血管疾患の危険因子の増加と関連している可能性があります。

例えば、Institute for Health Metrics and Evaluation（2023）によると、世界の喫煙者数は2019年に11億人に増加し、新規喫煙者の90％が25歳までに依存症になっています。

WHO（2023）によるもう1つの興味深い統計では、高血圧症の患者数が1990年から2019年にかけて倍増し、12億8,000万人に達したことが引用されています。

上記の危険因子の増加は、今後数年間に行われるバイパス手術の需要を増加させ、その結果、血液濃縮器の需要を高めます。

さらに、心血管疾患を発症しやすい老年人口の増加が、血液濃縮器市場の成長をさらに加速させる見通しです。WHO（2023）が提供したデータによると、2020年に世界中で約10億人が60歳以上でした。上記の資料は、2050年までに60歳以上の老年人口が倍増し、約21億人になると予測しています。また、80歳以上の人口は2020年～2050年に3倍に増え、4億2,600万人に達すると推定されています。

したがって、上記の要因が血液濃縮器市場の成長を加速させると予測されます。

しかし、熟練した専門家の不足や手術中の合併症が、血液濃縮器市場の抑制要因になる可能性があります。

COVID-19パンデミックは、ロックダウン、国境閉鎖、その他の製造、供給、輸入、輸出などの血液濃縮器市場に関連する活動の混乱につながったため、最初の数ヶ月間は血液濃縮器市場の成長に若干マイナスの影響を与えました。また、COVID-19の原因物質であるSARS-CoV-2ウイルスの蔓延の恐れや、パンデミックにまつわる不確実性のために、世界の多くの国が緊急時を除いて外来手術センター（ASC）の閉鎖を余儀なくされました。しかし、医療部門を含む産業全体の活動再開が血液濃縮器市場を押し上げており、2024年～2030年の予測期間における成長を促進する見込みです。

血液濃縮器市場のセグメント分析

血液濃縮器市場の製品タイプセグメントでは、小児用血液濃縮器カテゴリが2022年に71%の最高収益シェアを占めました。

心臓病を患う小児患者の増加が、小児用血液濃縮器の成長をもたらした主な理由です。NHS（2022）によると、英国では100人に1人の赤ちゃんが先天性心疾患を持って生まれています。

米国疾病予防管理センター（2022）の発表によると、心臓に欠陥を持って生まれた赤ちゃんの約4人に1人が重症先天性心疾患（CHD）です。

当レポートでは、世界の血液濃縮器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血液濃縮器市場レポートのイントロダクション

第2章 血液濃縮器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 血液濃縮器市場の主な要因の分析

• 血液濃縮器市場の促進要因
  • 心血管疾患の罹患率と負担の増加
  • 世界中での老年人口の負担の増大
  • 各国政府の取り組み
• 血液濃縮器市場の抑制要因と課題
  • 熟練した専門家の不足
  • 手術中の合併症
• 血液濃縮器市場の機会
  • 新興国における意識の高まりによる成長機会
  • 血液濃縮器を開発する必要性の高まり

第5章 血液濃縮器市場のポーターのファイブフォース分析

第6章 血液濃縮器市場に対するCOVID-19の影響分析

第7章 血液濃縮器の市場レイアウト

• 製品タイプ別
  • 小児用血液濃縮器
  • 成人用血液濃縮器
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 血液濃縮器市場の企業と製品のプロファイル

• Getinge AB
• LivaNova PLC
• Braile Biomedica
• Terumo Corporation
• MEDICA S.P.A.
• Andocor
• NIPRO
• STERIS
• Chalice Medical Ltd.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Hemoconcentrators Market
• Table 3: Hemoconcentrators Market in Global (2021-2030)
• Table 4: Hemoconcentrators Market in Global by Product Type (2021-2030)
• Table 5: Hemoconcentrators Market in Global by End User (2021-2030)
• Table 6: Hemoconcentrators Market in Global by Geography (2021-2030)
• Table 7: Hemoconcentrators Market in North America (2021-2030)
• Table 8: Hemoconcentrators Market in North America by Country (2021-2030)
• Table 9: Hemoconcentrators Market in the US (2021-2030)
• Table 10: Hemoconcentrators Market in Canada (2021-2030)
• Table 11: Hemoconcentrators Market in Mexico (2021-2030)
• Table 12: Hemoconcentrators Market in Europe (2021-2030)
• Table 13: Hemoconcentrators Market in Europe by Country (2021-2030)
• Table 14: Hemoconcentrators Market in France (2021-2030)
• Table 15: Hemoconcentrators Market in Germany (2021-2030)
• Table 16: Hemoconcentrators Market in the United Kingdom (2021-2030)
• Table 17: Hemoconcentrators Market in Italy (2021-2030)
• Table 18: Hemoconcentrators Market in Spain (2021-2030)
• Table 19: Hemoconcentrators Market in Rest of Europe (2021-2030)
• Table 20: Hemoconcentrators Market in APAC (2021-2030)
• Table 21: Hemoconcentrators Market in APAC by Country (2021-2030)
• Table 22: Hemoconcentrators Market in China (2021-2030)
• Table 23: Hemoconcentrators Market in Japan (2021-2030)
• Table 24: Hemoconcentrators Market in India (2021-2030)
• Table 25: Hemoconcentrators Market in Australia (2021-2030)
• Table 26: Hemoconcentrators Market in South Korea (2021-2030)
• Table 27: Hemoconcentrators Market in Rest of APAC (2021-2030)
• Table 28: Hemoconcentrators Market in Rest of the World (2021-2030)
• Table 29: Hemoconcentrators Market in RoW by Region (2021-2030)
• Table 30: Hemoconcentrators Market in Middle East (2021-2030)
• Table 31: Hemoconcentrators Market in Africa (2021-2030)
• Table 32: Hemoconcentrators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Hemoconcentrators Market
• Figure 3: Hemoconcentrators Market in Global (2021-2030)
• Figure 4: Hemoconcentrators Market in Global by Product Type (2021-2030)
• Figure 5: Hemoconcentrators Market in Global by End User (2021-2030)
• Figure 6: Hemoconcentrators Market in Global by Geography (2021-2030)
• Figure 7: Hemoconcentrators Market in North America (2021-2030)
• Figure 8: Hemoconcentrators Market in North America by Country (2021-2030)
• Figure 9: Hemoconcentrators Market in the US (2021-2030)
• Figure 10: Hemoconcentrators Market in Canada (2021-2030)
• Figure 11: Hemoconcentrators Market in Mexico (2021-2030)
• Figure 12: Hemoconcentrators Market in Europe (2021-2030)
• Figure 13: Hemoconcentrators Market in Europe by Country (2021-2030)
• Figure 14: Hemoconcentrators Market in France (2021-2030)
• Figure 15: Hemoconcentrators Market in Germany (2021-2030)
• Figure 16: Hemoconcentrators Market in the United Kingdom (2021-2030)
• Figure 17: Hemoconcentrators Market in Italy (2021-2030)
• Figure 18: Hemoconcentrators Market in Spain (2021-2030)
• Figure 19: Hemoconcentrators Market in Rest of Europe (2021-2030)
• Figure 20: Hemoconcentrators Market in APAC (2021-2030)
• Figure 21: Hemoconcentrators Market in APAC by Country (2021-2030)
• Figure 22: Hemoconcentrators Market in China (2021-2030)
• Figure 23: Hemoconcentrators Market in Japan (2021-2030)
• Figure 24: Hemoconcentrators Market in India (2021-2030)
• Figure 25: Hemoconcentrators Market in Australia (2021-2030)
• Figure 26: Hemoconcentrators Market in South Korea (2021-2030)
• Figure 27: Hemoconcentrators Market in Rest of APAC (2021-2030)
• Figure 28: Hemoconcentrators Market in Rest of the World (2021-2030)
• Figure 29: Hemoconcentrators Market in RoW by Region (2021-2030)
• Figure 30: Hemoconcentrators Market in Middle East (2021-2030)
• Figure 31: Hemoconcentrators Market in Africa (2021-2030)
• Figure 32: Hemoconcentrators Market in South America (2021-2030)
• Figure 33: Hemoconcentrators Market Drivers
• Figure 34: Hemoconcentrators Market Barriers
• Figure 35: Hemoconcentrators Market Opportunities
• Figure 36: PORTER'S Five Force Analysis

Hemoconcentrators Market By Product Type (Pediatric Hemoconcentrators And Adult Hemoconcentrators), By End-User (Hospitals And Ambulatory Surgical Centres), and by geography is estimated to register a growth at a remarkable CAGR forecast during 2024-2030 owing to a surge in the cases of cardiovascular diseases and growing burden of geriatric population globally

The global hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030. The hemoconcentrators market is slated to witness growth owing to factors such as the rising burden of cardiovascular disorders, the rising geriatric population, the increasing number of government initiatives by countries, and the growing focus on improving the safety, affordability, and usability of hemoconcentrators is expected to result in appreciable revenue growth in the hemoconcentrators market during the forecast period (2024-2030).

Hemoconcentrators Market Dynamics:

One of the noteworthy drivers of the hemoconcentrators market is the rise in the prevalence of cardiovascular diseases.

As per the data provided by the World Health Organization (WHO) 2022, cardiovascular disorders are considered the leading cause of death worldwide affecting about 17.9 million lives every year. Cardiovascular diseases requiring bypass surgeries mainly include disorders such as coronary artery disease, aortic stenosis, and edema, among others.

In another study by the World Heart Federation in the year 2019, it had estimated that more than 23 million lives will be affected globally owing to cardiovascular disorders by the year 2030.

The increase in the rates of cardiovascular diseases can be linked to an increase in the risk factors for cardiovascular diseases such as unhealthy lifestyle, tobacco usage, hypertension, diabetes, alcohol consumption, obesity, and others.

For instance, according to the Institute for Health Metrics and Evaluation (2023), the number of smokers worldwide increased to 1.1 billion in 2019, where 90% of all new smokers became addicted by the age of 25.

Another interesting statistic by the WHO (2023), quoted that the number of people living with hypertension doubled to 1.28 billion from 1990-2019.

The increase in the abovementioned risk factors will increase the demand for more bypass surgeries to take place in the upcoming years, thus raising the demand for hemoconcentrators.

Additionally, the rising geriatric population prone to the development of cardiovascular diseases is further going to accelerate the growth of the hemoconcentrators market. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The source mentioned above added by stating that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

Thereby, the above-mentioned factors are expected to accelerate the growth of the hemoconcentrators market.

However, the dearth of skilled professionals and complications during surgery may act as restraining factors for the hemoconcentrators market.

The COVID-19 pandemic had a slightly negative impact on the market growth of hemoconcentrators during the initial few months owing to the lockdown impositions, border closures, and others leading to the disruption in the manufacturing, supply, import, export, and other related activities of the hemoconcentrators market. Also, owing to the fear of the spread of the SARS-CoV-2 virus which is the causative agent for COVID-19, and uncertainties revolving around the pandemic, many countries across the world were forced to close down ambulatory surgical centers (ASCs) except in case of emergencies. However, the resumption of activities across industries including the healthcare sector has been uplifting the hemoconcentrators market and will drive growth during the forecast period from 2024-2030.

Hemoconcentrators Market Segment Analysis:

Hemoconcentrators Market by Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators), End-user (Hospitals and Ambulatory Surgical Centres), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the hemoconcentrators market, the pediatric hemoconcentrators category held the highest revenue share of 71% in 2022.

The increasing number of pediatric patients with heart diseases is the main reason responsible for the growth of pediatric hemoconcentrators. According to NHS 2022, one in a hundred babies are born with congenital heart disease in the UK.

As per the Centers for Disease Control and Prevention, 2022, about 1 in 4 babies born with a heart defect have a critical congenital heart defect (CHD).

The increasing importance of pediatric coronary artery bypass surgery (PCABS) for congenital heart disease in infants and children undergoing modern cardiac surgical procedures, because of its life-saving potential in unsuccessful coronary transfer operations is going to increase the demand for pediatric hemoconcentrators.

Due to the small size and low weight of pediatric patients among other factors, performing bypass surgery in infants and neonates is complicated. Pediatric hemoconcentrators help in reducing inflammatory cytokines and correcting electrolyte and acid-base imbalances, limit early postoperative RBCs transfusions, reduces swelling of the heart, and facilitate the closing of surgical incision for better outcome of pediatric cardiac surgery.

For example, CAPIOX® HC05 Hemoconcentrators by Terumo Corporation is a type of pediatric Hemoconcentrator that efficiently concentrates blood using a polysulfone membrane material at a high ultrafiltration rate.

Therefore, owing to the above-mentioned factors the pediatric hemoconcentrators category is expected to witness substantial growth in the overall hemoconcentrators market during the given forecast period.

North America is expected to dominate the overall Hemoconcentrators Market:

Among all the regions, North America held the largest share of 45% in the hemoconcentrators market in 2022.

This domination is owing to the surging prevalence of cardiovascular disorders such as heart failure, congenital heart disease, hypertension, and others, the growing government initiatives in the cardiovascular sector in the United States, and the presence of key players in the region is expected to propel the overall market growth.

According to the latest study conducted by the Centres for Disease Control and Prevention (CDC), one person dies every 34 seconds in the United States from cardiovascular disease. Also, as per the same source, about 697,000 people in the United States died from heart disease in 2020, in the United States and about 20.1 million adults aged 20 and older had coronary artery disease (CAD). The mortality rate can be controlled by treating or managing the disease through surgical procedures such as cardiac bypass surgery, ultimately increasing the demand for hemoconcentrators.

As per the above-mentioned source, congenital heart defects are the most common type of birth defect in the United States, affecting nearly 1% (about 40,000) of births per year. The American Heart Association projected that by 2035, more than 130 million US adults will have some type of heart disease.

Moreover, the increasing prevalence of risk factors for cardiovascular diseases such as hypertension, obesity, age, arteriosclerosis, and others will in turn drive the market for hemoconcentrators. As per the source, Million Heart, 2022, high blood pressure is the most prevalent heart disease in the US, as almost half of the population had been diagnosed with hypertension, in 2020.

Therefore, the above-mentioned factors are going to bolster the North America hemoconcentrators markets.

Hemoconcentrators Market Key Players:

Some of the key market players operating in the Hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO, STERIS, Chalice Medical Ltd., and others.

Recent Developmental Activities in the Hemoconcentrators Market:

In June 2022, STERIS plc completed the acquisition of Cantel Medical which was the parent company of Medivators Inc. and Minntech, leading manufacturers of hemoconcentrators.

Key Takeaways from the Hemoconcentrators Market Report Study

Market size analysis for current hemoconcentrators market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the hemoconcentrators market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.

Key companies dominating the global hemoconcentrators market.

Various opportunities available for the other competitor in the hemoconcentrators market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current hemoconcentrators market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for hemoconcentrators market growth in the coming future?

Target Audience who can be benefited from this Hemoconcentrators Market Report Study

Hemoconcentrators providers

Research organizations and consulting companies

Hemoconcentrators -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in hemoconcentrators

Various end users who want to know more about the hemoconcentrators market and the latest technological developments in the hemoconcentrators market.

Frequently Asked Questions for the Hemoconcentrators Market:

1. What are hemoconcentrators?

A hemoconcentrator is an ultrafiltration device consisting of semipermeable membrane fibers that remove plasma water and solutes. Blood passes through fibers of a microporous membrane, and since the hydrostatic pressure inside the fibers is higher than outside, effluent fluid can pass through the membrane and be drained.

2. What is the market for global hemoconcentrators?

The global hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030.

3. What are the drivers for the global hemoconcentrators market?

The hemoconcentrators market is expected to grow significantly owing to factors such as the rising burden of cardiovascular disorders, the rising geriatric population, and the increasing number of government initiatives by countries, among others during the given forecast period (2024-2030).

4. Who are the key players operating in the global hemoconcentrators market?

Some of the key market players operating in the hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO, STERIS, Chalice Medical Ltd., and others.

5. Which region has the highest share in the hemoconcentrators market?

North America is expected to dominate the overall hemoconcentrators market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large number of people suffering from cardiovascular diseases along with the rising geriatric population in the region. In addition, it is a highly potent market in terms of technological developments and launches along with the presence of key market players among other factors in the region.

Table of Contents

1.Hemoconcentrators Market Report Introduction

2. Hemoconcentrators Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Hemoconcentrators Market Key Factors Analysis

• 4.1. Hemoconcentrators Market Drivers
  • 4.1.1. Increase in the prevalence and burden of cardiovascular diseases
  • 4.1.2. The escalating burden of the geriatric population globally
  • 4.1.3. Government initiatives by the countries
• 4.2. Hemoconcentrators Market Restraints and Challenges
  • 4.2.1. The dearth of skilled professionals
  • 4.2.2. Complications during surgery
• 4.3. Hemoconcentrators Market Opportunities
  • 4.3.1. Growth opportunities in emerging countries owing to rising awareness
  • 4.3.2. Rising need to develop hemoconcentrators

5. Hemoconcentrators Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Hemoconcentrators Market

7. Hemoconcentrators Market Layout

• 7.1. By Product Type:
  • 7.1.1. Pediatric Hemoconcentrators
  • 7.1.2. Adult Hemoconcentrators
• 7.2 By End User
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centres
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.1.2. Canada Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.1.3. Mexico Hemoconcentrators Market in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.2.2. Germany Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.2.4. Italy Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.2.5. Spain Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Hemoconcentrators Market in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.3.2. Japan Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.3.3. India Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.3.4. Australia Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.3.5. South Korea Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia Pacific Hemoconcentrators Market in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.4.2. Africa Hemoconcentrators Market in USD million (2021-2030)
    • 7.3.4.3. South America Hemoconcentrators Market in USD million (2021-2030)

8. Hemoconcentrators Market Company and Product Profiles

• 8.1. Getinge AB
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. LivaNova PLC
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Braile Biomedica
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Terumo Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. MEDICA S.P.A.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Andocor
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. NIPRO
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. STERIS
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Chalice Medical Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us